Vishal C. Kalel

The paper identifies PEX38 as a novel, essential peroxin in Euglenozoa, evolved from a remnant GET-pathway factor, and highlights its role in peroxisomal membrane protein targeting and potential as a therapeutic target.

This study identifies small molecule inhibitors targeting the TbPEX6-TbPEX15 interaction in trypanosomatid parasites, showing trypanocidal activity in vitro.

This study identifies an FDA-approved inhibitor that targets glycosome membrane biogenesis in Leishmania parasites, effectively killing them including amastigote forms.